Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

Grace Anne Dorney Koppel was told she only had a few years left after her 2001 COPD diagnosis. Now, the couple provides the ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into ...

Around 400,000 people in Austria suffer from this lung disease. Stopping smoking is the most important treatment measure for ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

One in 13 Australians over the age of 40 have chronic obstructive pulmonary disease (COPD), but alarmingly only half of them know they have ...